[go: up one dir, main page]

DK1373263T3 - Heterocycliske forbindelser til aldringsrelaterede og diabetesbetingede vaskulære sygdomme - Google Patents

Heterocycliske forbindelser til aldringsrelaterede og diabetesbetingede vaskulære sygdomme

Info

Publication number
DK1373263T3
DK1373263T3 DK02722547T DK02722547T DK1373263T3 DK 1373263 T3 DK1373263 T3 DK 1373263T3 DK 02722547 T DK02722547 T DK 02722547T DK 02722547 T DK02722547 T DK 02722547T DK 1373263 T3 DK1373263 T3 DK 1373263T3
Authority
DK
Denmark
Prior art keywords
discloses
age
compounds
aging
diabetes
Prior art date
Application number
DK02722547T
Other languages
Danish (da)
English (en)
Inventor
Alangudi Sankaranarayanan
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1373263T3 publication Critical patent/DK1373263T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
DK02722547T 2001-04-05 2002-04-02 Heterocycliske forbindelser til aldringsrelaterede og diabetesbetingede vaskulære sygdomme DK1373263T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28138001P 2001-04-05 2001-04-05
PCT/IB2002/001137 WO2002085897A1 (en) 2001-04-05 2002-04-02 Heterocyclic compounds for aging-related and diabetic vascular complications
EP02722547A EP1373263B1 (en) 2001-04-05 2002-04-02 Heterocyclic compounds for aging-related and diabetic vascular complications

Publications (1)

Publication Number Publication Date
DK1373263T3 true DK1373263T3 (da) 2005-03-07

Family

ID=23077044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02722547T DK1373263T3 (da) 2001-04-05 2002-04-02 Heterocycliske forbindelser til aldringsrelaterede og diabetesbetingede vaskulære sygdomme

Country Status (21)

Country Link
US (2) US7223777B2 (hu)
EP (1) EP1373263B1 (hu)
JP (2) JP4485744B2 (hu)
KR (1) KR100785109B1 (hu)
CN (1) CN1259316C (hu)
AT (1) ATE280766T1 (hu)
AU (1) AU2002253432B2 (hu)
BR (1) BR0208561A (hu)
CA (1) CA2439593C (hu)
CZ (1) CZ20032013A3 (hu)
DE (1) DE60201740T2 (hu)
DK (1) DK1373263T3 (hu)
ES (1) ES2231685T3 (hu)
HU (1) HUP0400823A3 (hu)
MX (1) MXPA03008089A (hu)
PL (1) PL365441A1 (hu)
PT (1) PT1373263E (hu)
RU (1) RU2291154C2 (hu)
SI (1) SI1373263T1 (hu)
WO (1) WO2002085897A1 (hu)
ZA (1) ZA200306370B (hu)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355645A4 (en) * 2000-12-29 2005-02-23 Alteon Inc METHOD FOR THE TREATMENT OF FIBROUS OR OTHER IIIC INDICATIONS
BR0208561A (pt) * 2001-04-05 2004-03-30 Torrent Pharmaceuticals Ltd Compostos heterocìclicos para complicações vasculares diabéticas e relacionadas ao envelhecimento
CN100436445C (zh) * 2003-02-07 2008-11-26 第一制药株式会社 吡唑衍生物
ATE478859T1 (de) * 2003-02-07 2010-09-15 Daiichi Sankyo Co Ltd Pyrazolderivat
US7932272B2 (en) 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
US7354938B2 (en) * 2004-03-23 2008-04-08 Amgen Inc. Pyrazole compounds and uses related thereto
US20050241110A1 (en) * 2004-04-09 2005-11-03 Bruce Baker Ergonomic handles, especially for garden tools
WO2006002983A1 (en) * 2004-07-06 2006-01-12 Novartis Ag Combination of organic compounds
US20090227799A1 (en) * 2004-08-09 2009-09-10 Kazutaka Nakamoto Novel Antimalarial Agent Containing Heterocyclic Compound
CA2579313A1 (en) * 2004-09-17 2006-03-30 Exelixis, Inc. Pyrazole kinase modulators and methods of use as c-kit or fit-3 kinase inhibitors
US20060167066A1 (en) 2004-12-20 2006-07-27 Genentech, Inc. Pyrrolidine inhibitors of IAP
US20080275134A1 (en) * 2005-02-24 2008-11-06 University Of Washington Methods for Treatment of Retinal Degenerative Disease
WO2006106711A1 (ja) 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
RU2380365C1 (ru) * 2005-10-31 2010-01-27 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Гетероциклические замещенные производные пиримидина и содержащий их противогрибковый агент
CN101300250B (zh) * 2005-10-31 2012-09-05 卫材R&D管理有限公司 杂环取代吡啶衍生物及含有该衍生物的抗真菌剂
KR101003569B1 (ko) 2005-10-31 2010-12-22 에자이 알앤드디 매니지먼트 가부시키가이샤 헤테로환 치환 피리딘 유도체 및 이들을 함유하는 항진균제
SA07280004B1 (ar) 2006-02-02 2011-10-29 استرازينيكا ايه بي ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات
WO2008004096A1 (en) * 2006-07-05 2008-01-10 Pfizer Products Inc. Pyrazole derivatives as cytochrome p450 inhibitors
US8183264B2 (en) 2006-09-21 2012-05-22 Eisai R&D Managment Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
NZ597247A (en) 2006-11-29 2013-06-28 Abbott Lab Inhibitors of diacylglycerol O-acylotransferase type 1 enzyme
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
EP2148858A4 (en) 2007-04-30 2011-01-26 Genentech Inc IPA INHIBITORS
FR2918570B1 (fr) * 2007-07-09 2012-10-05 Engelhard Lyon DIGLYCATION DES AGEs.
EP2203161B1 (en) * 2007-09-26 2018-05-09 Indiana University Research and Technology Corporation Quinone derivatives, pharmaceutical compositions, and uses thereof
CA2709664A1 (en) 2007-12-26 2009-07-02 Eisai R&D Management Co., Ltd. Method for manufacturing heterocycle substituted pyridine derivatives
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
KR100989093B1 (ko) 2008-01-18 2010-10-25 한화제약주식회사 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
US20110034378A1 (en) 2008-01-25 2011-02-10 Chaitanya Dutt Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
RU2356570C1 (ru) * 2008-02-26 2009-05-27 Нина Сергеевна Вихриева Косметическая композиция
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
EP2318395A4 (en) 2008-08-02 2011-10-26 Genentech Inc IPA INHIBITORS
EP2345328A4 (en) * 2008-09-19 2014-06-25 Sumitomo Chemical Co COMPOSITION FOR USE IN AGRICULTURE
EP2346505B1 (en) * 2008-10-16 2014-04-23 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
RU2402325C1 (ru) * 2009-02-02 2010-10-27 Государственное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ лечения нейрососудистых осложнений сахарного диабета
CN102459175A (zh) 2009-05-07 2012-05-16 托蓝特医药公司 用于治疗糖尿病的哌啶衍生物
KR101040162B1 (ko) * 2009-05-12 2011-06-09 주식회사 카모스 감시카메라의 브라켓
WO2011051198A2 (de) 2009-10-30 2011-05-05 Bayer Cropscience Ag Pyridin-derivate als pflanzenschutzmittel
KR101018881B1 (ko) * 2009-11-03 2011-03-04 주식회사 엑스트론아이앤티 감시카메라용 브라켓
PL2565184T3 (pl) * 2010-04-28 2016-06-30 Toray Industries Środek terapeutyczny i środek zapobiegawczy przeciwko chorobie alzheimera
WO2012020738A1 (ja) * 2010-08-09 2012-02-16 武田薬品工業株式会社 複素環化合物およびその用途
SMT201900059T1 (it) 2013-02-22 2019-02-28 Samumed Llc Gamma-dichetoni come attivatori della via di segnalazione wnt/beta-catenina
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
RU2697512C2 (ru) * 2014-05-22 2019-08-15 Ф. Хоффманн-Ля Рош Аг Производные индолин-2-она и 1,3-дигидро-пирроло[3,2-c]пиридин-2-она
SI3206686T1 (sl) * 2014-08-20 2020-03-31 Samumed, Llc Gama-diketoni za zdravljenje in preprečevanje staranja kože in gub
FR3026947B1 (fr) * 2014-10-10 2017-12-08 Basf Beauty Care Solutions France Sas Activite deglycation d'une combinaison d'un extrait de salvia miltiorrhiza et de niacine et/ou de niacinamide
BR112017021631A2 (pt) 2015-04-08 2018-07-03 Torrent Pharmaceuticals Limited composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto
CN106806886B (zh) * 2015-12-01 2021-07-16 华中科技大学 一种快速消除口臭的口气清新剂及其医药用途
WO2019113542A1 (en) 2017-12-07 2019-06-13 Amplyx Pharmaceuticals, Inc. Heterocycle substituted pyridine derivative antifungal agents
CN108157405B (zh) * 2018-02-06 2020-10-02 上海应用技术大学 一种灭蟑螂饵剂及其制备方法和应用
EP3810115B1 (en) 2018-06-25 2024-07-17 Basilea Pharmaceutica International AG, Allschwil Pyridine derivatives substituted by heterocyclic ring and amino group
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
DE202022104072U1 (de) 2022-07-19 2022-07-29 Siva Subramanian Narayanasamy Heterozyklisch substituierte pyridinderivate antimykotische Mittel

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501484A (en) * 1968-01-15 1970-03-17 Miles Lab Certain substituted 3 - (2-indolyl)-1,2,5,6-tetrahydropyridines and derivatives thereof
US3501312A (en) * 1968-07-22 1970-03-17 Eastman Kodak Co Direct positive silver halide emulsions containing trimethine cyanine dyes
US3957805A (en) * 1974-07-24 1976-05-18 American Cyanamid Company Substituted pyridines and diazines and methods of preparing the same
US5272176A (en) * 1984-03-19 1993-12-21 The Rockefeller University Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
US5514676A (en) 1984-03-19 1996-05-07 The Rockefeller University Amino-benzoic acids and derivatives, and methods of use
US5137916A (en) 1985-11-14 1992-08-11 The Rockefeller University Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
US4758583A (en) 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
EP0339496A3 (en) 1988-04-26 1991-05-08 Ono Pharmaceutical Co., Ltd. Aminoguanidine derivatives
ATE194835T1 (de) * 1990-04-25 2000-08-15 Nissan Chemical Ind Ltd Pyridazinonderivat
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
DE4210502A1 (de) * 1992-03-31 1993-10-07 Bayer Ag Verwendung von 3-aminosubstituierten Isoxazolderivaten zur Bekämpfung von Endoparasiten, neue 3-aminosubstituierte Isoxazolderivate und Verfahren zu ihrer Herstellung
ES2203677T3 (es) 1995-01-18 2004-04-16 Alteon, Inc. Uso de compuestos de tiazolio para prevenir y invertir la formacion de productos finales de glicosilacion avanzada.
US5656261A (en) 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
US6228858B1 (en) * 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
JPH09291082A (ja) * 1996-02-27 1997-11-11 Sankyo Co Ltd イソキサゾール誘導体
AU7553198A (en) * 1997-06-12 1998-12-30 Sumitomo Pharmaceuticals Company, Limited Pyrazole derivatives
AU3512400A (en) * 1999-03-05 2000-09-21 Kansas University Medical Center Novel post-amadori inhibitors of advanced glycation reactions
US20010044445A1 (en) * 1999-04-08 2001-11-22 Bamaung Nwe Y. Azole inhibitors of cytokine production
WO2000066101A2 (en) * 1999-04-30 2000-11-09 City Of Hope Method of inhibiting glycation product formation
FR2796278B1 (fr) 1999-07-16 2002-05-03 Oreal Utilisation d'au moins un hydroxystilbene comme agent anti-glycation
BR9915962A (pt) * 1999-10-06 2003-01-07 Torrent Pharmaceuticals Ltd Composto da série do piridìnio, processos para a preparação de composto da série do piridìnio e de uma formulação parenteral, uso de um composto, composição farmacêutica para tratar complicações diabéticas e doenças associadas ao envelhecimento, e, método para tratar um paciente diabético e para prevenir ou tratar doenças causadas por complicações associadas à diabetes e ao envelhecimento
HK1044335B (en) * 1999-10-06 2004-09-10 Torrent Pharmaceuticals Ltd New compound for treating aging-related diseases and diabetic vascular complications, its preparation method, and therapeutic use
FR2802420B1 (fr) 1999-12-21 2002-02-22 Oreal Utilisation du 3,3', 5,5'-tetrahydroxystilbene comme agent anti-glycation
BR0208561A (pt) * 2001-04-05 2004-03-30 Torrent Pharmaceuticals Ltd Compostos heterocìclicos para complicações vasculares diabéticas e relacionadas ao envelhecimento

Also Published As

Publication number Publication date
CA2439593C (en) 2010-02-09
CA2439593A1 (en) 2002-10-31
CN1498217A (zh) 2004-05-19
EP1373263B1 (en) 2004-10-27
US7223777B2 (en) 2007-05-29
KR20030086340A (ko) 2003-11-07
MXPA03008089A (es) 2004-01-22
ZA200306370B (en) 2004-06-07
HUP0400823A2 (hu) 2004-07-28
DE60201740T2 (de) 2005-11-03
ES2231685T3 (es) 2005-05-16
HK1061234A1 (en) 2004-09-10
WO2002085897A8 (en) 2002-11-28
SI1373263T1 (en) 2005-04-30
CZ20032013A3 (cs) 2003-12-17
BR0208561A (pt) 2004-03-30
US20030045554A1 (en) 2003-03-06
WO2002085897A9 (en) 2004-04-01
JP2010100640A (ja) 2010-05-06
WO2002085897A1 (en) 2002-10-31
EP1373263A1 (en) 2004-01-02
AU2002253432B2 (en) 2005-03-24
CN1259316C (zh) 2006-06-14
DE60201740D1 (de) 2004-12-02
US20070167493A1 (en) 2007-07-19
HUP0400823A3 (en) 2010-06-28
JP4485744B2 (ja) 2010-06-23
PT1373263E (pt) 2005-03-31
RU2003128076A (ru) 2005-04-10
PL365441A1 (en) 2005-01-10
RU2291154C2 (ru) 2007-01-10
KR100785109B1 (ko) 2007-12-12
ATE280766T1 (de) 2004-11-15
JP2004529154A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
DK1373263T3 (da) Heterocycliske forbindelser til aldringsrelaterede og diabetesbetingede vaskulære sygdomme
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20050828L (no) lndol-3-svovelderivater
NO20041041L (no) Fenetanolaminderivater for behandling av respiratoriske sykdommer
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
NO983688L (no) Serin-protease-inhibitorer
ATE406353T1 (de) Piperidin-derivaten und deren verwendung bei der behandlung von durch chemokinen oder h1 vermittelten krankheiten
NO20070570L (no) Forbindelser.
NO20052487L (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
NO20052182L (no) Nye forbindelser
NO330888B1 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
NO20060733L (no) Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer
DE60315032D1 (de) Phenylalanin enamidderivate
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
NO20026081L (no) Nye forbindelser
WO2002055491A3 (en) 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
WO2023150790A3 (en) Novel and highly selective sars-cov-2 mpro inhibitors
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
NO20062664L (no) Fremgangsmate for fremstilling av 4-pentafluorid-sulfanyl-benzoylguanidiner